Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Non Operating Income (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Non Operating Income for 13 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 182300.0% to -$1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$26000.0, a 2500.0% decrease, with the full-year FY2025 number at -$26000.0, down 2500.0% from a year prior.
  • Non Operating Income was -$1.8 million for Q4 2025 at Ekso Bionics Holdings, down from -$19000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.3 million in Q2 2025 to a low of -$1.8 million in Q4 2025.
  • A 5-year average of $42833.3 and a median of $0.0 in 2022 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: surged 5500.0% in 2023, then crashed 182300.0% in 2025.
  • Ekso Bionics Holdings' Non Operating Income stood at -$329000.0 in 2021, then surged by 482.37% to $1.3 million in 2022, then plummeted by 114.23% to -$179000.0 in 2023, then soared by 100.56% to $1000.0 in 2024, then plummeted by 182300.0% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Non Operating Income are -$1.8 million (Q4 2025), -$19000.0 (Q3 2025), and $1.3 million (Q2 2025).